Trade

with

Nanoviricides Inc
(Amex: NNVC)
AdChoices
3.56
-0.14
-3.78%
After Hours :
3.58
+0.02
+0.56%

Open

3.70

Previous Close

3.70

Volume (Avg)

277.36k (274.50k)

Day's Range

3.50-3.70

52Wk Range

2.67-6.65

Market Cap.

200.96M

Dividend Rate ( Yield )

-

Beta

0.77

Shares Outstanding

56.45M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 0

    • Net Income

    • -14.11M

    • Market Cap.

    • 200.96M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.77

    • Forward P/E

    • -16.95

    • Price/Sales

    • -

    • Price/Book Value

    • 7.03

    • Price/Cash flow

    • -29.76

      • EBITDA

      • -10.80M

      • Return on Capital %

      • -46.27

      • Return on Equity %

      • -77.07

      • Return on Assets %

      • -46.27

      • Book Value/Share

      • 0.51

      • Shares Outstanding

      • 56.45M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Buy
        • 1 Year Price Target

        • 7.00

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -0.20

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 0.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • -

          • 7.80

          • Net Income

            Q/Q (last year)

          • -

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 0.00

          • 6.10

          • Net Income

            5-Year Annual Average

          • -

          • 3.73

          • Dividends

            5-Year Annual Average

          • -

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -

            • 69.92

            • Pre-Tax Margin

            • -

            • 21.84

            • Net Profit Margin

            • -

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • -

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • -

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.32

              • 0.32

              • Current Ratio

              • 30.70

              • 1.92

              • Quick Ratio

              • 29.91

              • 1.31

              • Interest Coverage

              • -3.56

              • 17.64

              • Leverage Ratio

              • 1.56

              • 2.03

              • Book Value/Share

              • 0.51

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -13.37

                • 21.74

                • P/E Ratio 5-Year High

                • -33.55

                • 193.96

                • P/E Ratio 5-Year Low

                • -4.07

                • 87.26

                • Price/Sales Ratio

                • -

                • 3.68

                • Price/Book Value

                • 7.26

                • 3.66

                • Price/Cash Flow Ratio

                • -29.76

                • 13.76

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -77.07

                    (-78.60)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • -46.27

                    (-58.70)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • -44.85

                    (-68.00)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • -

                  • 90.07k

                  • Inventory Turnover

                  • -

                  • 2.46

                  • Asset Turnover

                  • -

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -8.67M
                  Operating Margin
                  -
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -29.76
                  Ownership

                  Institutional Ownership

                  24.95%

                  Top 10 Institutions

                  25.05%

                  Mutual Fund Ownership

                  6.21%

                  Float

                  72.22%

                  5% / Insider Ownership

                  15.67%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard Total Stock Mkt Idx

                  •  

                    635,591

                  • 0.00

                  • 1.13

                  • iShares Russell 2000 (AU)

                  •  

                    623,637

                  • -1.01

                  • 1.36

                  • Vanguard Extended Market Index Fund

                  •  

                    344,847

                  • 3.14

                  • 0.61

                  • iShares Russell 2000 Growth

                  •  

                    288,566

                  • 0.77

                  • 0.63

                  • Fidelity Spartan® Extended Mkt Indx Fd

                  •  

                    143,363

                  • 0.00

                  • 0.26

                  • CREF Stock

                  •  

                    120,437

                  • 0.00

                  • 0.22

                  • Bridgeway Ultra Small Company Market

                  •  

                    100,000

                  • 0.00

                  • 0.18

                  • iShares Micro-Cap

                  •  

                    98,131

                  • 0.00

                  • 0.21

                  • AQR Small Cap Momentum Fund

                  •  

                    57,800

                  • 0.00

                  • 0.11

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Theracour Pharma Inc

                  •  

                    9,531,429

                  • -71.43%

                  • 19.12

                  • Vanguard Group, Inc.

                  •  

                    946,301

                  • +17.98%

                  • 1.73

                  • State Street Corp

                  •  

                    370,292

                  • +2,003.93%

                  • 0.67

                  • Goldman, Sachs & Co.

                  •  

                    225,863

                  • +10.45%

                  • 0.41

                  • Geode Capital Management, LLC

                  •  

                    204,531

                  • +16.22%

                  • 0.37

                  • Bridgeway Capital Management, Inc

                  •  

                    143,000

                  • 0.00%

                  • 0.26

                  • BNY Mellon Asset Management Ltd.

                  •  

                    111,146

                  • +246.45%

                  • 0.20

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Distressed

                  Style

                  Small Core

                  Nanoviricides Inc a development stage nano-biopharmaceutical company, engages in the discovery, development, and commercialization of anti-viral therapeutics primarily in the United States.

                  Key People

                  Dr. Eugene Seymour,M.D.,M.P.H.

                  CEO/Director

                  Dr. Anil Diwan,PhD

                  Chairman of the Board/Director/President

                  Ms. Meeta Vyas

                  CFO/Chief Accounting Officer

                  Mr. Stanley Glick

                  Director

                  Dr. Milton Boniuk

                  Director

                  • Nanoviricides Inc

                  • 135 Wood Street

                  • West Haven, CT 6516

                  • USA.Map

                  • Phone: +1 203 937-6137

                  • Fax: +1 203 859-5095

                  • nanoviricides.com

                  Incorporated

                  2000

                  Employees

                  6

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: